Toll like receptor 3 and viral infections of nervous system

Journal of the Neurological Sciences

Volumn 372, Issue , 2017, Pages 40-48

  Verma, Rajesh ^a   Bharti, Kavita ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Central nervous system; dsRNA; Encephalitis; Flavivirus; Single nucleotide polymorphism; Toll like receptor 3

Indexed keywords

TOLL LIKE RECEPTOR 3; ANTIVIRUS AGENT; TLR3 PROTEIN, HUMAN;

ALPHAVIRUS INFECTION; ASTROCYTE CULTURE; CENTRAL NERVOUS SYSTEM INFECTION; DENGUE; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFLUENZA A; INNATE IMMUNITY; MEASLES; NEUROPATHOLOGY; NONHUMAN; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TICK BORNE ENCEPHALITIS; VIRUS INFECTION; ANIMAL; BIBLIOGRAPHIC DATABASE; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; GENETICS; IMMUNOLOGY; METABOLISM; STATISTICS AND NUMERICAL DATA;

ANIMALS; ANTIVIRAL AGENTS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; DATABASES, BIBLIOGRAPHIC; HUMANS; TOLL-LIKE RECEPTOR 3;

EID: 84996482972     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2016.11.034     Document Type: Review

References (94)

1. [1] Alexopoulou, L., Holt, A.C., Medzhitov, R., Flavell, R.A., Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 413:6857 (2001), 732–738.
2. [2] Lafon, M., Megret, F., Meuth, S.G., Simon, O., Velandia Romero, M.L., Lafage, M., et al. Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis. J. Immunol. 180:11 (2008), 7506–7515.
3. [3] Bsibsi, M., Ravid, R., Gveric, D., van Noort, J.M., Broad expression of toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61:11 (2002), 1013–1021.
4. [4] Nishiya, T., DeFranco, A.L., Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the toll-like receptors. J. Biol. Chem. 279:18 (2004), 19008–19017.
5. [5] Carpentier, P.A., Duncan, D.S., Miller, S.D., Glial toll-like receptor signaling in centralnervous systeminfection and autoimmunity. Brain Behav. Immun. 22:2 (2008), 140–147.
6. [6] Marcondes, M.C., Spina, C., Bustamante, E., Fox, H., Increased toll-like receptor signaling pathways characterize CD8 + cells in rapidly progressive SIV infection. Biomed. Res. Int., 2013, 2013, 796014.
7. [7] Takeuchi, O., Akira, S., Pattern recognition receptors and inflammation. Cell 140:6 (2010), 805–820.
8. [8] Schroder, K., Tschopp, J., The inflammasomes. Cell 140:6 (2010), 821–832.
9. [9] Iwasaki, A., Medzhitov, R., Regulation of adaptive immunity by the innate immune system. Science 327:5963 (2010), 291–295.
10. [10] Volhard, C., Wieschaus, E., Mutations affecting segment number and polarity in Drosophila. Nature 287 (1980), 795–801.
11. [11] Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.M., Hoffmann, J.A., The dorsoventral regulatory gene cassette spatzle/toll/cactus controls the potent antifungal response in drosophila adults. Cell 86:6 (1996), 973–983.
12. [12] Medzhitov, R., Preston-Hurlburt, P., Janeway, C.A. Jr., A human homologue of the drosophila toll protein signals activation of adaptive immunity. Nature 388:6640 (1997), 394–397.
13. [13] Trinchieri, G., Sher, A., Cooperation of toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7:3 (2007), 179–190.
14. [14] O'Neill, L.A., Bowie, A.G., The family of five: TIR-domain-containing adaptors in toll-like receptor signalling. Nat. Rev. Immunol. 7:5 (2007), 353–364.
15. [15] Akira, S., Takeda, K., Kaisho, T., Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:8 (2001), 675–680.
16. [16] Akira, S., TLR signaling. Curr. Top. Microbiol. Immunol. 311 (2006), 1–16.
17. [17] Häcker, H., Redecke, V., Blagoev, B., Kratchmarova, I., Hsu, L.C., Wang, G.G., Kamps, M.P., Raz, E., Wagner, H., Hacker, G., et al. Specificity in toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:7073 (2006), 204–207.
18. [18] Shim, J.H., Xiao, C., Paschal, A.E., Bailey, S.T., Rao, P., Hayden, M.S., Lee, K.Y., Bussey, C., Steckel, M., Tanaka, N., et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19:22 (2005), 2668–2681.
19. [19] Kaiser, W.J., Offermann, M.K., Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J. Immunol. 174:8 (2005), 4942–4952.
20. [20] Bsibsi, M., Persoon-Deen, C., Verwer, R.W., Meeuwsen, S., Ravid, R., Van Noort, J.M., Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53:7 (2006), 688–695.
21. [21] Yeh, H.J., He, Y.Y., Xu, J., Hsu, C.Y., Deuel, T.F., Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury. The Journal of neuroscience: the official journal of the Society for Neuroscience 18:10 (1998), 3699–3707.
22. [22] Endres, M., Fan, G., Hirt, L., Fujii, M., Matsushita, K., Liu, X., et al. Ischemic brain damage in mice after selectively modifying BDNF or NT4 gene expression. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 20:1 (2000), 139–144.
23. [23] Carpentier, P.A., Begolka, W.S., Olson, J.K., Elhofy, A., Karpus, W.J., Miller, S.D., Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49:3 (2005), 360–374.
24. [24] Lafon, M., Megret, F., Lafage, M., Prehaud, C., The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. Journal of molecular neuroscience: MN. 29:3 (2006), 185–194.
25. [25] Cameron, J.S., Alexopoulou, L., Sloane, J.A., DiBernardo, A.B., Ma, Y., Kosaras, B., et al. Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. The Journal of neuroscience: the official journal of the Society for Neuroscience 27:47 (2007), 13033–13041.
26. [26] Bell, J.K., Botos, I., Hall, P.R., Askins, J., Shiloach, J., Segal, D.M., et al. The molecular structure of the toll-like receptor 3 ligand-binding domain. Proc. Natl. Acad. Sci. U. S. A. 102:31 (2005), 10976–10980.
27. [27] Moumad, K., Lascorz, J., Bevier, M., Khyatti, M., Ennaji, M.M., Benider, A., et al. Genetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa. G3 (Bethesda) 3:6 (2013), 971–977.
28. [28] Yang, C.A., Raftery, M.J., Hamann, L., Guerreiro, M., Grutz, G., Haase, D., et al. Association of TLR3-hyporesponsiveness and functional TLR3 L412F polymorphism with recurrent herpes labialis. Hum. Immunol. 73:8 (2012), 844–851.
29. [29] Dhiman, N., Ovsyannikova, I.G., Vierkant, R.A., Ryan, J.E., Pankratz, V.S., Jacobson, R.M., et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 26:14 (2008), 1731–1736.
30. [30] Gorbea, C., Makar, K.A., Pauschinger, M., Pratt, G., Bersola, J.L., Varela, J., et al. A role for toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J. Biol. Chem. 285:30 (2010), 23208–23223.
31. [31] Ranjith-Kumar, C.T., Miller, W., Sun, J., Xiong, J., Santos, J., Yarbrough, I., et al. Effects of single nucleotide polymorphisms on toll-like receptor 3 activity and expression in cultured cells. J. Biol. Chem. 282:24 (2007), 17696–17705.
32. [32] Kurt-Jones, E.A., Chan, M., Zhou, S., Wang, J., Reed, G., Bronson, R., et al. Herpes simplex virus 1 interaction with toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U. S. A. 101:5 (2004), 1315–1320.
33. [33] Lund, J., Sato, A., Akira, S., Medzhitov, R., Iwasaki, A., Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:3 (2003), 513–520.
34. [34] Weber, F., Wagner, V., Rasmussen, S.B., Hartmann, R., Paludan, S.R., Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80:10 (2006), 5059–5064.
35. [35] Guo, Y., Audry, M., Ciancanelli, M., Alsina, L., Azevedo, J., Herman, M., et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J. Exp. Med. 208:10 (2011), 2083–2098.
36. [36] Davey, G.M., Wojtasiak, M., Proietto, A.I., Carbone, F.R., Heath, W.R., Bedoui, S., Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo. J. Immunol. 184:5 (2010), 2243–2246.
37. [37] Li, J., Ye, L., Wang, X., Hu, S., Ho, W., Induction of interferon-gamma contributes to toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes. J. Neurosci. Res. 90:2 (2012), 399–406.
38. [38] Reinert, L.S., Harder, L., Holm, C.K., Iversen, M.B., Horan, K.A., Dagnaes-Hansen, F., et al. TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice. J. Clin. Invest. 122:4 (2012), 1368–1376.
39. [39] Willmann, O., Ahmad-Nejad, P., Neumaier, M., Hennerici, M.G., Fatar, M., Toll-like receptor 3 immune deficiency may be causative for HSV-2-associated mollaret meningitis. Eur. Neurol. 63:4 (2010), 249–251.
40. [40] Zhang, S.Y., Jouanguy, E., Ugolini, S., Smahi, A., Elain, G., Romero, P., et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:5844 (2007), 1522–1527.
41. [41] Menasria, R., Boivin, N., Lebel, M., Piret, J., Gosselin, J., Boivin, G., Both TRIF and IPS-1 adaptor proteins contribute to the cerebral innate immune response against herpes simplex virus 1 infection. J. Virol. 87:13 (2013), 7301–7308.
42. [42] Casrouge, A., Zhang, S.Y., Eidenschenk, C., Jouanguy, E., Puel, A., Yang, K., et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:5797 (2006), 308–312.
43. [43] Sancho-Shimizu, V., Perez de Diego, R., Lorenzo, L., Halwani, R., Alangari, A., Israelsson, E., et al. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J. Clin. Invest. 121:12 (2011), 4889–4902.
44. [44] Perez de Diego, R., Sancho-Shimizu, V., Lorenzo, L., Puel, A., Plancoulaine, S., Picard, C., et al. Human TRAF3 adaptor molecule deficiency leads to impaired toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33:3 (2010), 400–411.
45. [45] Lim, H.K., Seppanen, M., Hautala, T., Ciancanelli, M.J., Itan, Y., Lafaille, F.G., et al. TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk. Neurology 83:21 (2014), 1888–1897.
46. [46] Debiasi, R.L., Tyler, K.L., West Nile virus meningoencephalitis. Nat. Clin. Pract. Neurol. 2:5 (2006), 264–275.
47. [47] Wang, T., Town, T., Alexopoulou, L., Anderson, J.F., Fikrig, E., Flavell, R.A., Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:12 (2004), 1366–1373.
48. [48] Daffis, S., Samuel, M.A., Suthar, M.S., Gale, M. Jr., Diamond, M.S., Toll-like receptor 3 has a protective role against West Nile virus infection. J. Virol. 82:21 (2008), 10349–10358.
49. [49] Kong, K.F., Delroux, K., Wang, X., Qian, F., Arjona, A., Malawista, S.E., et al. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J. Virol. 82:15 (2008), 7613–7623.
50. [50] Mackenzie, J.S., Gubler, D.J., Petersen, L.R., Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10:12 Suppl (2004), S98–109.
51. [51] Han, Y.W., Choi, J.Y., Uyangaa, E., Kim, S.B., Kim, J.H., Kim, B.S., et al. Distinct dictation of Japanese encephalitis virus-induced neuroinflammation and lethality via triggering TLR3 and TLR4 signal pathways. PLoS Pathog., 10(9), 2014, e1004319.
52. [52] Jiang, R., Ye, J., Zhu, B., Song, Y., Chen, H., Cao, S., Roles of TLR3 and RIG-I in mediating the inflammatory response in mouse microglia following Japanese encephalitis virus infection. Journal of immunology research, 2014, 2014, 787023.
53. [53] Biyani, S., Garg, R.K., Jain, A., Malhotra, H.S., Kumar, R., Prakash, S., et al. Toll-like receptor-3 gene polymorphism in patients with Japanese encephalitis. J. Neuroimmunol. 286 (2015), 71–76.
54. [54] Kindberg, E., Mickiene, A., Ax, C., Akerlind, B., Vene, S., Lindquist, L., et al. A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. The Journal of infectious diseases. 197:2 (2008), 266–269.
55. [55] Kindberg, E., Vene, S., Mickiene, A., Lundkvist, A., Lindquist, L., Svensson, L., A functional toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection. The Journal of infectious diseases. 203:4 (2011), 523–528.
56. [56] Mickienė, A., Pakalniene, J., Nordgren, J., Carlsson, B., Hagbom, M., Svensson, L., et al. Polymorphisms in chemokine receptor 5 and toll-like receptor 3 genes are risk factors for clinical tick-borne encephalitis in the Lithuanian population. PLoS One, 9(9), 2014, e106798.
57. [57] Barkhash, A.V., Voevoda, M.I., Romaschenko, A.G., Association of single nucleotide polymorphism rs3775291 in the coding region of the TLR3 gene with predisposition to tick-borne encephalitis in a Russian population. Antivir. Res. 99:2 (2013), 136–138.
58. [58] Solomon, T., Dung, N.M., Vaughn, D.W., Kneen, R., Thao, L.T., Raengsakulrach, B., et al. Neurological manifestations of dengue infection. Lancet 355:9209 (2000), 1053–1059.
59. [59] Misra, U.K., Kalita, J., Syam, U.K., Dhole, T.N., Neurological manifestations of dengue virus infection. J. Neurol. Sci. 244:1–2 (2006), 117–122.
60. [60] Verma, R., Sharma, P., Garg, R.K., Atam, V., Singh, M.K., Mehrotra, H.S., Neurological complications of dengue fever: experience from a tertiary center of north India. Annals of Indian Academy of Neurology 14:4 (2011), 272–278.
61. [61] Tsai, Y.T., Chang, S.Y., Lee, C.N., Kao, C.L., Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell. Microbiol. 11:4 (2009), 604–615.
62. [62] Nasirudeen, A.M., Wong, H.H., Thien, P., Xu, S., Lam, K.P., Liu, D.X., RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl. Trop. Dis., 5(1), 2011, e926.
63. [63] Torres, S., Hernandez, J.C., Giraldo, D., Arboleda, M., Rojas, M., Smit, J.M., et al. Differential expression of toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease. PLoS Negl. Trop. Dis., 7(2), 2013, e2060.
64. [64] Conceicao, T.M., El-Bacha, T., Villas-Boas, C.S., Coello, G., Ramirez, J., Montero-Lomeli, M., et al. Gene expression analysis during dengue virus infection in HepG2 cells reveals virus control of innate immune response. The Journal of infection. 60:1 (2010), 65–75.
65. [65] Liang, Z., Wu, S., Li, Y., He, L., Wu, M., Jiang, L., et al. Activation of toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-beta in cultured hepatoma cells. PLoS One, 6(8), 2011, e23346.
66. [66] Alagarasu, K., Bachal, R.V., Memane, R.S., Shah, P.S., Cecilia, D., Polymorphisms in RNA sensing toll like receptor genes and its association with clinical outcomes of dengue virus infection. Immunobiology 220:1 (2015), 164–168.
67. [67] Chatterjee, S.N., Chakravarti, S.K., Mitra, A.C., Sarkar, J.K., Virological investigation of cases with neurological complications during the outbreak of haemorrhagic fever in Calcutta. J. Indian Med. Assoc. 45:6 (1965), 314–316.
68. [68] Priya, R., Patro, I.K., Parida, M.M., TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus. Virus Res. 189 (2014), 194–205.
69. [69] Li, Y.G., Siripanyaphinyo, U., Tumkosit, U., Noranate, N., AN, A., Pan, Y., et al. Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells. Virol. J., 9, 2012, 114.
70. [70] Her, Z., Teng, T.S., Tan, J.J., Teo, T.H., Kam, Y.W., Lum, F.M., et al. Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response. EMBO molecular medicine 7:1 (2015), 24–41.
71. [71] McMinn, P.C., An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:1 (2002), 91–107.
72. [72] Lei, X., Sun, Z., Liu, X., Jin, Q., He, B., Wang, J., Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by toll-like receptor 3. J. Virol. 85:17 (2011), 8811–8818.
73. [73] Zhu, K., Yang, J., Luo, K., Yang, C., Zhang, N., Xu, R., et al. TLR3 signaling in macrophages is indispensable for the protective immunity of invariant natural killer T cells against enterovirus 71 infection. PLoS Pathog., 11(1), 2015, e1004613.
74. [74] Pang, L., Gong, X., Liu, N., Xie, G., Gao, W., Kong, G., et al. A polymorphism in melanoma differentiation-associated gene 5 may be a risk factor for enterovirus 71 infection. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20:10 (2014), O711–O717.
75. [75] Oshiumi, H., Okamoto, M., Fujii, K., Kawanishi, T., Matsumoto, M., Koike, S., et al. The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. J. Immunol. 187:10 (2011), 5320–5327.
76. [76] Abe, Y., Fujii, K., Nagata, N., Takeuchi, O., Akira, S., Oshiumi, H., et al. The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice. J. Virol. 86:1 (2012), 185–194.
77. [77] Tatematsu, M., Nishikawa, F., Seya, T., Matsumoto, M., Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA. Nat. Commun., 4, 2013, 1833.
78. [78] Hidaka, F., Matsuo, S., Muta, T., Takeshige, K., Mizukami, T., Nunoi, H., A missense mutation of the toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Clin. Immunol. 119:2 (2006), 188–194.
79. [79] Weiss, R., Laengle, J., Sachet, M., Shurygina, A.P., Kiselev, O., Egorov, A., et al. Interleukin-24 inhibits influenza a virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis. Antivir. Res. 123 (2015), 93–104.
80. [80] Suh, H.S., Zhao, M.L., Rivieccio, M., Choi, S., Connolly, E., Zhao, Y., et al. Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response. J. Virol. 81:18 (2007), 9838–9850.
81. [81] Rivieccio, M.A., Suh, H.S., Zhao, Y., Zhao, M.L., Chin, K.C., Lee, S.C., et al. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J. Immunol. 177:7 (2006), 4735–4741.
82. [82] Fujimoto, C., Nakagawa, Y., Ohara, K., Takahashi, H., Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8 + cytotoxic T lymphocytes. Int. Immunol. 16:1 (2004), 55–63.
83. [83] Sironi, M., Biasin, M., Cagliani, R., Forni, D., De Luca, M., Saulle, I., Lo Caputo, S., Mazzotta, F., Macías, J., Pineda, J.A., Caruz, A., Clerici, M., A common polymorphism in TLR3 confers natural resistance to HIV-1 infection. J. Immunol. 15:188(2) (2012), 818–823.
84. [84] Dai, M., Wang, X., Li, J.L., Zhou, Y., Sang, M., Liu, J.B., Wu, J.G., Ho, W.Z., Activation of TLR3/interferon signaling pathway by bluetongue virus results in HIV inhibition in macrophages. FASEB J. 29:12 (2015), 4978–4988.
85. [85] Jackson, A.C., Update on rabies. Curr. Opin. Neurol. 15:3 (2002), 327–331.
86. [86] Prehaud, C., Megret, F., Lafage, M., Lafon, M., Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79:20 (2005), 12893–12904.
87. [87] Ménager, P., Roux, P., Megret, F., Bourgeois, J.P., Le Sourd, A.M., Danckaert, A., et al. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri bodies. PLoS Pathog., 5(2), 2009, e1000315.
88. [88] Ishizaki, Y., Takemoto, M., Kira, R., Kusuhara, K., Torisu, H., Sakai, Y., et al. Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis. J. Neurovirol. 14:6 (2008), 486–491.
89. [89] Edelmann, K.H., Richardson-Burns, S., Alexopoulou, L., Tyler, K.L., Flavell, R.A., Oldstone, M.B., Does toll-like receptor 3 play a biological role in virus infections?. Virology 322:2 (2004), 231–238.
90. [90] Tabeta, K., Georgel, P., Janssen, E., Du, X., Hoebe, K., Crozat, K., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. U. S. A. 101:10 (2004), 3516–3521.
91. [91] Medhi, S., Deka, M., Deka, P., Swargiary, S.S., Hazam, R.K., Sharma, M.P., et al. Promoter region polymorphism & expression profile of toll like receptor-3 (TLR-3) gene in chronic hepatitis C virus (HCV) patients from India. Indian J. Med. Res. 134 (2011), 200–207.
92. [92] So, E.Y., Kang, M.H., Kim, B.S., Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the toll-like receptor 3. Glia 53:8 (2006), 858–867.
93. [93] So, E.Y., Kim, B.S., Theiler's virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production. Glia 57:11 (2009), 1216–1226.
94. [94] Netea, M.G., Wijmenga, C., O'Neill, L.A., Genetic variation in toll-like receptors and disease susceptibility. Nat. Immunol. 13:6 (2012), 535–542.